Storia in 4 fonti

FDA begins push to study psychedelics for mental health disorders - UPI.com

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

upi.comStai leggendo3 mesi fa

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.

cnbc.com3 mesi fa

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.